Dakota Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Sell
10,573
-23,375
-69% -$5.83M 0.05% 260
2025
Q4
$8.18M Buy
33,948
+7,651
+29% +$1.96M 0.15% 124
2025
Q3
$7.2M Buy
26,297
+8,094
+44% +$2.21M 0.15% 127
2025
Q2
$4.7M Buy
18,203
+3,014
+20% +$719K 0.1% 165
2025
Q1
$3.4M Buy
15,189
+2,709
+22% +$632K 0.08% 186
2024
Q4
$2.85M Buy
+12,480
New +$3M 0.07% 218
2023
Q4
Sell
-1,368
Closed -$202K 700
2023
Q3
$202K Sell
1,368
-1,669
-55% -$302K 0.01% 597
2023
Q2
$664K Buy
3,037
+1,269
+72% +$283K 0.03% 330
2023
Q1
$387K Sell
1,768
-1,042
-37% -$226K 0.03% 416
2022
Q4
$585K Buy
2,810
+43
+2% +$9.45K 0.04% 320
2022
Q3
$604K Sell
2,767
-633
-19% -$144K 0.05% 307
2022
Q2
$713K Buy
+3,400
New +$724K 0.07% 232

Other funds holding RMD

Dakota Wealth Management's RMD Position: Q1 2026 in Review

Dakota Wealth Management reduced its ResMed (RMD) stake by 69% in Q1 2026, selling an estimated $5.83M and leaving 10,573 shares worth $2.37M. The position accounts for 0.05% of the portfolio, ranked #260.

Dakota Wealth Management first reported a position in RMD in Q2 2022 and has held it in 12 quarters since. The position peaked at $8.18M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Dakota Wealth Management held 10,573 shares of ResMed worth $2.37M as of Q1 2026.
  • Dakota Wealth Management sold 23,375 ResMed shares in Q1 2026, an estimated $5.83M.
  • ResMed made up 0.05% of Dakota Wealth Management's portfolio in Q1 2026, its #260 holding.
  • Dakota Wealth Management first reported a position in ResMed in Q2 2022 and has held it in 12 quarters since.
  • Dakota Wealth Management's ResMed position peaked at $8.18M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Dakota Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.